Excel Industries Ltd Valuation Improves Amid Mixed Market Returns

Valuation Metrics: A Closer Look

Excel Industries currently trades at a price of ₹981.65, up 4.25% on the day, with a 52-week range between ₹801.00 and ₹1,438.00. The company’s price-to-earnings (P/E) ratio stands at 16.23, a figure that has contributed to its upgraded valuation grade from very attractive to attractive as of 30 March 2026. This P/E is notably lower than several peers in the specialty chemicals sector, such as Paushak, which trades at a P/E of 35.93, and Punjab Chemicals at 21.6, indicating a relatively cheaper earnings multiple for Excel Industries.

Price-to-book value (P/BV) is another key metric where Excel Industries shows strength, currently at 0.72. This sub-1 multiple suggests the stock is trading below its book value, a factor often interpreted as undervaluation by value investors. In comparison, many peers in the sector have higher P/BV ratios, reinforcing Excel’s relative price attractiveness.

Enterprise value to EBITDA (EV/EBITDA) ratio for Excel Industries is 9.93, which is competitive within the sector. For instance, 3B Blackbio, a peer, trades at an EV/EBITDA of 17.89, while Dharmaj Crop, rated very attractive, is close at 10.04. This metric indicates that Excel Industries is valued reasonably relative to its operational cash flow generation.

Financial Performance and Quality Indicators

Despite the improved valuation metrics, Excel Industries’ return on capital employed (ROCE) and return on equity (ROE) remain modest at 4.66% and 4.44% respectively. These returns are relatively low for the specialty chemicals industry, which often demands higher capital efficiency for premium valuations. The dividend yield stands at 1.41%, offering some income to shareholders but not a significant yield compared to other sectors.

The company’s PEG ratio is reported as 0.00, which may indicate either zero or negligible earnings growth expectations factored into the price, or a data anomaly. This lack of growth premium could be a reason for the cautious Mojo Grade of Sell, despite the valuation upgrade.

Peer Comparison and Market Context

When compared to its peers, Excel Industries’ valuation appears attractive but not without risks. Companies like Paushak and Mahamaya Lifesciences are classified as very expensive, with P/E ratios above 23 and EV/EBITDA multiples exceeding 13, suggesting that Excel’s valuation discount may be justified by its lower profitability and growth prospects.

Conversely, some peers such as Dharmaj Crop and Advance Agrolife share similar attractive valuations but differ in growth outlook and operational metrics. Astec Lifesciences and Heranba Industries are marked as risky due to loss-making status, highlighting the varied risk profiles within the sector.

Stock Performance Relative to Sensex

Excel Industries has outperformed the Sensex in the short term, with a 1-week return of 8.70% versus the Sensex’s -1.12%, and a 1-month return of 8.38% compared to the Sensex’s -0.34%. Year-to-date, the stock has gained 5.10%, while the Sensex has declined by 9.84%. However, over longer horizons, the stock’s performance is mixed; it has underperformed the Sensex over 1 year (-27.27% vs -5.68%) and 5 years (-17.97% vs 46.13%), though it has outpaced the benchmark over 10 years with a 222.65% return against the Sensex’s 174.18%.

Mojo Score and Grade Implications

Excel Industries holds a Mojo Score of 34.0 and a current Mojo Grade of Sell, upgraded from Strong Sell on 30 March 2026. This upgrade reflects the improved valuation parameters but also signals caution due to underlying financial and operational challenges. The micro-cap status of the company adds an additional layer of risk, as liquidity and market volatility can impact price movements more significantly than larger peers.

The valuation grade change from very attractive to attractive suggests that while the stock remains reasonably priced, some of the earlier undervaluation has been corrected by recent price appreciation. Investors should weigh this against the company’s modest returns and sector dynamics before making allocation decisions.

Sector Outlook and Investment Considerations

The specialty chemicals sector is characterised by cyclical demand, regulatory pressures, and the need for continuous innovation. Excel Industries’ valuation metrics position it as a relatively affordable option within this space, but its lower profitability ratios and growth uncertainties temper enthusiasm.

Investors seeking exposure to this sector might consider balancing Excel Industries with peers that offer stronger growth or profitability profiles, albeit at higher valuations. The company’s recent price gains and valuation upgrade could attract value-oriented investors looking for turnaround potential, but the Sell rating advises prudence.

Conclusion: Valuation Attractiveness Balanced by Operational Challenges

Excel Industries Ltd’s recent valuation upgrade from very attractive to attractive reflects a recalibrated price level that offers a reasonable entry point relative to earnings and book value. The company’s P/E of 16.23 and P/BV of 0.72 stand out favourably against many peers, suggesting that the market is pricing in some recovery or stability.

However, the modest ROCE and ROE, combined with a Sell Mojo Grade and micro-cap classification, indicate that investors should remain cautious. The stock’s mixed performance relative to the Sensex over various timeframes further underscores the need for a balanced approach.

For investors prioritising valuation, Excel Industries presents an opportunity, but those seeking growth or higher returns might find better alternatives within the specialty chemicals sector or beyond. Continuous monitoring of operational improvements and market conditions will be essential to reassess the stock’s attractiveness going forward.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →